AMGN 241129 215.00C (AMGN241129C215000) Stock Options, News & Quotes

US OptionsDetailed Quotes

AMGN241129C215000

Watchlist

0.00
0.000.00%

15min DelayClose Nov 27 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

RBC Capital Maintains Amgen(AMGN.US) With Buy Rating, Cuts Target Price to $360
Moomoo News19:31 ET · Ratings
Beigene's commercialized products for multiple indications are included in the new version of the national medical insurance drug list.
Beigene (06160) announced that its self-developed anti-PD-1 antibody drug, Baizean (Tiragolumab injection), and BTK inhibitor, Baiyueze (Zebutini capsule), have added three new indications and one indication has been included in the National Medical Insurance Catalog; Luye Pharma's co-introduced product, Baituowei (Goserelin injection microspheres), has added one indication included in the National Medical Insurance Catalog; Amgen's authorized introduced product, Kyprolis (Carfilzomib for injection), has successfully been renewed. The National Medical Insurance Catalog will be officially implemented starting January 1, 2025. This time the company's products Baizean and Baiyueze.
Sina Hong Kong stocks.19:14 ET
Should You Be Excited About Amgen Inc.'s (NASDAQ:AMGN) 56% Return On Equity?
Yahoo FinanceNov 28 07:00 ET
Wednesday Ends With Index Decline | Wall Street Today
Kevin TraversNov 27 16:08 ET
AMGN Stock Down Despite Strong Data From Obesity Drug Study
Zacks Nov 27 14:30 ET
RBC Capital Maintains Outperform on Amgen, Lowers Price Target to $330
BenzingaNov 27 12:02 ET · Ratings

Comments

Shaaaw

Nov 27 06:52

Today, $Amgen (AMGN.US)$ announced the P2 trial results for MariTide, which only include the safety profile for the 420 mg dose escalation cohorts (cherry-picking at it's finest again).
I suspect they chose not to present the full safety profile, given that the weight loss results for the 120 mg and 280 mg QM cohorts, in obese non-diabetics (without dose escalations), at week 16 in P2 are consistent with the P1 results (see slide 1). So, it is likely that the 120 mg and 280 mg QM (without dose...

Kevin Travers

Nov 26 15:12

Columns S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today

The market again hit records Tuesday, reacting mostly positively toward incoming President-Elect Trump's comments overnight that he would put a 25% tariff on our neighbors in Canada and Mexico and 35% on Chinese goods, our three largest trading partners.
According to Census Bureau data, there are price hikes in the goods on 41% of the U.S.'s total imports; there has been $1.6T trade so far in 2024. A blanket ...

Ben the Oracle

Nov 26 10:56

THIS IS NO BRAINER

$Amgen (AMGN.US)$ A 20% weight loss reduction in one year is fantastic and healthy from a medical standpoint. A 5 foot 4 inches woman at 180 pounds would loss guaranteed 36 pounds over 1 year be down to a much healthier 144 pounds. This is impressive results. I don’t understand the selloff. The human body should lose weight in a healthy fashion. I don’t know what you guys are expecting . This is great news .

PeanutButterr

Nov 26 09:55

$Amgen (AMGN.US)$ feels overdone for decent Phase 2 data.

Kevin Travers

Nov 26 09:02

Columns Dow Falls After Record, Trump Talks Tariffs on Day One | Live Stock

Good morning, traders. Happy Tuesday, November 26th. The Dow closed at a high yesterday, and the S&P 500 hit a trading record.
You will not make it through today without the news and animal spirits moving markets. My name is Kevin Travers, here is what's live:
$Amgen (AMGN.US)$ investors tightened their belts and shaved 11% of the stock price Tuesday after the firm said in a press release their Phase 2 study of MariTide showed ...

Live Stock Financial Podcast. What are you watching on the market?